Nuclear Receptor ROR-Gamma Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4144631
- 128 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nuclear Receptor ROR-Gamma market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nuclear Receptor ROR-Gamma market segmented into
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
Based on the end-use, the global Nuclear Receptor ROR-Gamma market classified into
Hospital
Clinic
Others
Based on geography, the global Nuclear Receptor ROR-Gamma market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NUCLEAR RECEPTOR ROR-GAMMA INDUSTRY
2.1 Summary about Nuclear Receptor ROR-Gamma Industry
2.2 Nuclear Receptor ROR-Gamma Market Trends
2.2.1 Nuclear Receptor ROR-Gamma Production & Consumption Trends
2.2.2 Nuclear Receptor ROR-Gamma Demand Structure Trends
2.3 Nuclear Receptor ROR-Gamma Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 VPR-66
4.2.2 INV-17
4.2.3 GSK-2981278
4.2.4 BBI-6000
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 VPR-66
5.2.2 INV-17
5.2.3 GSK-2981278
5.2.4 BBI-6000
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 VPR-66
6.2.2 INV-17
6.2.3 GSK-2981278
6.2.4 BBI-6000
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 VPR-66
7.2.2 INV-17
7.2.3 GSK-2981278
7.2.4 BBI-6000
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 VPR-66
8.2.2 INV-17
8.2.3 GSK-2981278
8.2.4 BBI-6000
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 VPR-66
9.2.2 INV-17
9.2.3 GSK-2981278
9.2.4 BBI-6000
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 4SC AG
10.1.2 Advinus Therapeutics Ltd.
10.1.3 Arrien Pharmaceuticals, LLC
10.1.4 Aurigene Discovery Technologies Limited
10.1.5 Biogen, Inc.
10.1.6 Brickell Biotech, Inc.
10.1.7 Bristol-Myers Squibb Company
10.1.8 Celgene Corporation
10.1.9 Genentech, Inc.
10.1.10 Genfit SA
10.1.11 GlaxoSmithKline Plc
10.1.12 Hanmi Pharmaceuticals, Co. Ltd.
10.1.13 Karo Bio AB
10.1.14 Lead Pharma Holding B.V.
10.1.15 Nuevolution AB
10.1.16 Phenex Pharmaceuticals AG
10.1.17 Reata Pharmaceuticals, Inc.
10.1.18 Teijin Pharma Limited
10.1.19 Visionary Pharmaceuticals, Inc.
10.1.20 Vitae Pharmaceuticals, Inc.
10.2 Nuclear Receptor ROR-Gamma Sales Date of Major Players (2017-2020e)
10.2.1 4SC AG
10.2.2 Advinus Therapeutics Ltd.
10.2.3 Arrien Pharmaceuticals, LLC
10.2.4 Aurigene Discovery Technologies Limited
10.2.5 Biogen, Inc.
10.2.6 Brickell Biotech, Inc.
10.2.7 Bristol-Myers Squibb Company
10.2.8 Celgene Corporation
10.2.9 Genentech, Inc.
10.2.10 Genfit SA
10.2.11 GlaxoSmithKline Plc
10.2.12 Hanmi Pharmaceuticals, Co. Ltd.
10.2.13 Karo Bio AB
10.2.14 Lead Pharma Holding B.V.
10.2.15 Nuevolution AB
10.2.16 Phenex Pharmaceuticals AG
10.2.17 Reata Pharmaceuticals, Inc.
10.2.18 Teijin Pharma Limited
10.2.19 Visionary Pharmaceuticals, Inc.
10.2.20 Vitae Pharmaceuticals, Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Nuclear Receptor ROR-Gamma Product Type Overview
Table Nuclear Receptor ROR-Gamma Product Type Market Share List
Table Nuclear Receptor ROR-Gamma Product Type of Major Players
Table Brief Introduction of 4SC AG
Table Brief Introduction of Advinus Therapeutics Ltd.
Table Brief Introduction of Arrien Pharmaceuticals, LLC
Table Brief Introduction of Aurigene Discovery Technologies Limited
Table Brief Introduction of Biogen, Inc.
Table Brief Introduction of Brickell Biotech, Inc.
Table Brief Introduction of Bristol-Myers Squibb Company
Table Brief Introduction of Celgene Corporation
Table Brief Introduction of Genentech, Inc.
Table Brief Introduction of Genfit SA
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Hanmi Pharmaceuticals, Co. Ltd.
Table Brief Introduction of Karo Bio AB
Table Brief Introduction of Lead Pharma Holding B.V.
Table Brief Introduction of Nuevolution AB
Table Brief Introduction of Phenex Pharmaceuticals AG
Table Brief Introduction of Reata Pharmaceuticals, Inc.
Table Brief Introduction of Teijin Pharma Limited
Table Brief Introduction of Visionary Pharmaceuticals, Inc.
Table Brief Introduction of Vitae Pharmaceuticals, Inc.
Table Products & Services of 4SC AG
Table Products & Services of Advinus Therapeutics Ltd.
Table Products & Services of Arrien Pharmaceuticals, LLC
Table Products & Services of Aurigene Discovery Technologies Limited
Table Products & Services of Biogen, Inc.
Table Products & Services of Brickell Biotech, Inc.
Table Products & Services of Bristol-Myers Squibb Company
Table Products & Services of Celgene Corporation
Table Products & Services of Genentech, Inc.
Table Products & Services of Genfit SA
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Hanmi Pharmaceuticals, Co. Ltd.
Table Products & Services of Karo Bio AB
Table Products & Services of Lead Pharma Holding B.V.
Table Products & Services of Nuevolution AB
Table Products & Services of Phenex Pharmaceuticals AG
Table Products & Services of Reata Pharmaceuticals, Inc.
Table Products & Services of Teijin Pharma Limited
Table Products & Services of Visionary Pharmaceuticals, Inc.
Table Products & Services of Vitae Pharmaceuticals, Inc.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nuclear Receptor ROR-Gamma Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nuclear Receptor ROR-Gamma Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nuclear Receptor ROR-Gamma Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nuclear Receptor ROR-Gamma Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
